Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

News & Events

How much is the right amount of therapy?

In this blog, CliniKids Director Professor Andrew Whitehouse and Research Development Manager Sarah Pillar explore one of the most common questions when it comes to support for autistic children - how much is the right amount of therapy?

News & Events

Following your child's interest

In this blog, Senior Speech Pathologist Sally Grauaug and Speech Pathology Clinical Lead Aria May share tips on following your child's interest.

News & Events

What is SCERTS?

In this blog, Senior Speech Pathologist Sally Grauaug and Speech Pathology Clinical Lead Aria May discuss the model SCERTS and how it can support your child's communication level.

What is autism?

Autism is a complex developmental condition which results in differences in the way in which a person interacts, learns and behaves.

Research

Genome-Wide Analysis of Genetic Risk Factors for Rheumatic Heart Disease in Aboriginal Australians Provides Support for Pathogenic Molecular Mimicry

Rheumatic heart disease (RHD) after group A streptococcus (GAS) infections is heritable and prevalent in Indigenous populations. Molecular mimicry between human and GAS proteins triggers proinflammatory cardiac valve-reactive T cells.

Research

Initiating an undiagnosed diseases program in the Western Australian public health system

We describe the initiation and summary outcomes of a public health system approach for complex undiagnosed patients- the Undiagnosed Diseases Program - WA

Research

Mental health problems among 4–17-year-olds with hearing problems: results from a nationally representative study

Clinicians caring for children and young people with hearing problems should be alert for heightened risk of specific mental health problems based on age and the nature of hearing problems.

Research

Early introduction of food reduces food allergy – Pro and Con

When an infant is developmentally ready, a variety of nutritious foods should be introduced including the ‘more allergenic’ foods during infancy

Research

A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors

In this. i study the MTD and RP2D, safety, PK, and preliminary activity of single-agent ribociclib were investigated in patients with neuroblastoma.